Related Experiment Video
Updated: May 10, 2026

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Erythema multiforme in children: the steroid debate
1BC Children's Hospital, Department of Pediatrics, Room K4-226, Ambulatory Care Bldg, 4480 Oak St, Vancouver, BC V6H 3V4, Canada.
Erythema multiforme (EM) in children typically does not require systemic steroids for minor cases, though topical treatments may help. Systemic steroid use for severe EM major is debated, necessitating individualized treatment decisions.
Area of Science:
- Pediatric Dermatology
- Immunology
Background:
- Erythema multiforme (EM) is a common skin condition in children, characterized by target lesions.
- Clinical decisions regarding steroid treatment for EM in pediatric patients require careful consideration.
Purpose of the Study:
- To determine when to administer steroid treatment for pediatric erythema multiforme.
- To differentiate management strategies for EM minor versus EM major.
Main Methods:
- Review of current recommendations and existing evidence for steroid use in pediatric EM.
- Analysis of factors influencing treatment decisions based on disease severity.
Main Results:
- Systemic steroids are generally not recommended for EM minor; topical steroids may offer some benefit.
- Evidence for and against systemic steroid use in EM major is conflicting, with a lack of randomized controlled trials.
Conclusions:
- Management of pediatric EM should be guided by disease severity.
- Consultation with a dermatologist is advised for complex cases of EM major.
- Further research is needed to establish definitive steroid treatment guidelines for EM.
Related Concept Videos
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Myocarditis III: Medical Management
Drug Dosing: Infants and Children
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...

